cytocom, inc:Cytocom Inc.
Cytocom Inc.
2021年10月21日—CytocomInc.(CBLI.US)總部位於美國科羅拉多州科林斯堡,為一家臨床階段的生物製藥公司,針對癌症、自體免疫、發炎和傳染性疾病開發新型小分子免疫 ...。其他文章還包含有:「CytocomInc(CBLI)」、「CytocomInc(CBLI)」、「CytocomInc.AnnouncesCompletedMerger...」、「CytocomInc.AnnouncesCompletedMergerwith...」、「CytocomIncOld」、「Cytocom」、「Cytocom」、「DevelopingANewClassofImmunotherapies」
查看更多 離開網站Cytocom Inc (CBLI)
https://invest.cnyes.com
鉅亨美股頻道提供你最完整的CBLI - Cytocom Inc (CBLI)、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、盈餘獲 ...
Cytocom Inc (CBLI)
https://invest.cnyes.com
鉅亨美股頻道提供你最完整的CBLI - Cytocom Inc (CBLI)、美股公司資料、美股股票代號、美股新聞、股價走勢、技術線圖、財報分析、外資分析師評等、歷史股價、盈餘獲 ...
Cytocom Inc. Announces Completed Merger ...
https://www.sec.gov
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers ...
Cytocom Inc. Announces Completed Merger with ...
https://www.prnewswire.com
(Cytocom or Company), a leading biopharmaceutical company creating next-generation therapies that focus on immune homeostasis, today ...
Cytocom IncOld
https://www.bloomberg.com
Company profile page for Cytocom Inc/Old including stock price, company news, executives, board members, and contact information.
Cytocom
https://www.cytocom.com
CYTO-400 program therapies are proenkephalin analogs developed to target multiple receptors associated with cancer, inflammatory, autoimmune, and infectious ...
Cytocom
https://www.prnewswire.com
(Nasdaq: CBLI), a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, ...
Developing A New Class of Immunotherapies
https://www.cytocom.com
Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel small molecule immunotherapies targeting autoimmune, inflammatory, ...